Myriad Withdrawing Financial Guidance for FY2020 Due to Business Impact from Coronavirus Pandemic
SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, […]
SALT LAKE CITY, April 08, 2020 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, […]
BELTSVILLE, Md., April 08, 2020 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and […]
ALPHARETTA, Ga., April 08, 2020 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments […]
NEEDHAM, Mass., April 08, 2020 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving […]
SAN FRANCISCO, April 08, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating […]
– XBAW Filters Qualified and Designed into 5G Small Cell Product by Tier-1 Customer –– Shipped XBAW Filters for 5G […]
Shenzhen, China, April 08, 2020 (GLOBE NEWSWIRE) — ATIF Holdings Limited (the “Company” or Nasdaq: ATIF), a company providing financial […]
RESEARCH TRIANGLE PARK, N.C., April 08, 2020 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will […]
DUBLIN, Ireland, April 08, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization […]
STAMFORD, Conn., April 08, 2020 (GLOBE NEWSWIRE) — Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing […]